Skip to main content

Your CDMO from Drug Substance to Drug Product

  • Drug development to Commercialization services
  • For pharmaceutical and biopharmaceutical industries
  • At all stages of drug development
  • Drug Substance

    Gain from our strong experience in API development and manufacturing.

  • Sterile Drug Product

    Benefit from our state-of the-art facility for development and manufacturing of your injectable Drug Product.

  • Specialities

    Discover our Specialties from GMP cosmetics to high quality Cholesterol and Vitamin D analog products.

    Discover CARBOGEN AMCIS’ CDMO services

    Learn how CARBOGEN AMCIS can support you through the various clinical phases to bring your new drug from bench to market.

    A global presence with
    in Switzerland, UK, France, Netherlands & China
    More than
    of experience in clinical API development
    Production from gram to several
    scale manufacturing for API production
    Up to
    of capacity for API production
    • CARBOGEN AMCIS announces successful ANVISA audit of its facility in China

      BUBENDORF, Switzerland (19 March 2024) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai.
    • CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance

      Manchester, UK (20 June 2023) – CARBOGEN AMCIS Manchester, a member of the Switzerland-based CARBOGEN AMCIS Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, won the Manufacturing and Resource Efficiency Award at the prestigious Chemistry Industry Awards last week.
    • CARBOGEN AMCIS announces successful FDA and Swissmedic inspections of its facilities in Switzerland

      BUBENDORF, Switzerland (02 June 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at its headquarters in Bubendorf, Switzerland and a Swissmedic routine inspection at Bubendorf, Aarau and Neuland, Switzerland.

      Upcoming Events

      CARBOGEN AMCIS is a Contract Development and Manufacturing Organization (CDMO) committed to providing comprehensive solutions for Drug Substance and Drug Product development. With dedication, we assist pharmaceutical and biopharmaceutical companies in the successful development, manufacturing, and market launch of their innovative drugs.

      As a Pharma CDMO, we have been at the forefront of Pharmaceutical contract manufacturing for numerous years, leveraging our extensive experience to deliver high-quality services and support to our valued clients.

      Read more
      Drug Substance CDMO:

      At CARBOGEN AMCIS, we excel in Drug Substance development, offering comprehensive support throughout the entire drug development lifecycle. Our capabilities include process development, optimization, and scalable manufacturing of active pharmaceutical ingredients (APIs). With a focus on quality, safety, and efficiency, we enable our clients to streamline their drug substance development processes, accelerating the path to market approval. CARBOGEN AMCIS has experience in development & manufacture of HiPo APIs.

      Drug Product CDMO:

      Our expertise in Drug Product development encompasses a wide range of pharmaceutical formulations. From formulation design to commercial-scale manufacturing, we specialize in bringing your drug product to market efficiently and in compliance with regulatory standards. Our state-of-the-art facility and seasoned professionals ensure that your drug product is manufactured with precision and meets the highest quality standards.

      Cholesterol and Vitamin D manufacturer:

      Leveraging our versatile capabilities, CARBOGEN AMCIS also specializes in the production of Cholesterol & Lanolin Derivatives, alongside Vitamin D & D2 analogs. Our proficiency in formulating and manufacturing these essential compounds underscores our commitment to addressing diverse needs, whether for pharmaceuticals, food supplements, or other applications. Whether your project involves cholesterol-related solutions or Vitamin D enhancements, we are ready to apply our expertise to bring your vision to fruition.

      Partner with CARBOGEN AMCIS, and let us be your trusted collaborator in turning innovative drug concepts into successful market realities.